Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G Roberts

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2003
The phase III trial in the era of targeted therapy: unraveling the "go or no go" decisionThomas G Roberts, Thomas J Lynch, Bruce A Chabner
The Oncologist|June 18, 2002
Choosing chemotherapy for lung cancer based on cost: not yetThomas G Roberts, Thomas J Lynch, Bruce A Chabner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancerRebecca A Miksad, Mithat Gönen, Thomas J Lynch, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
Economic evaluation of a Bayesian model to predict late-phase success of new chemical entitiesAsher D Schachter, Marco F Ramoni, Gianluca Baio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Trends in the use and role of biomarkers in phase I oncology trialsBernardo H L Goulart, Jeffrey W Clark, Homer H Pien, et al.
Chemical Science|August 30, 2018
Transfer of photosynthetic NADP<sup>+</sup>/NADPH recycling activity to a porous metal oxide for highly specific, electrochemically-driven organic synthesisBhavin Siritanaratkul, Clare F Megarity, Thomas G Roberts, et al.
JAMA|November 4, 2004
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trialsThomas G Roberts, Bernardo H Goulart, Lee Squitieri, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2003
The phase III trial in the era of targeted therapy: unraveling the "go or no go" decisionThomas G Roberts, Thomas J Lynch, Bruce A Chabner
The Oncologist|June 18, 2002
Choosing chemotherapy for lung cancer based on cost: not yetThomas G Roberts, Thomas J Lynch, Bruce A Chabner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancerRebecca A Miksad, Mithat Gönen, Thomas J Lynch, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
Economic evaluation of a Bayesian model to predict late-phase success of new chemical entitiesAsher D Schachter, Marco F Ramoni, Gianluca Baio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Trends in the use and role of biomarkers in phase I oncology trialsBernardo H L Goulart, Jeffrey W Clark, Homer H Pien, et al.
Chemical Science|August 30, 2018
Transfer of photosynthetic NADP<sup>+</sup>/NADPH recycling activity to a porous metal oxide for highly specific, electrochemically-driven organic synthesisBhavin Siritanaratkul, Clare F Megarity, Thomas G Roberts, et al.
JAMA|November 4, 2004
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trialsThomas G Roberts, Bernardo H Goulart, Lee Squitieri, et al.
Pageof 2